NitroGlycerin — Class I drug recall D-0114-2018
Terminated recall by Advanced Pharma Inc., reported 2017-12-27, distributed nationwide. Subpotent Drug: found to be below the specification for labeled assay.
| Recall number | D-0114-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Advanced Pharma Inc., Houston, TX, United States |
| Recall initiated | 2017-06-09 |
| Classified | 2017-12-20 |
| Reported by FDA | 2017-12-27 |
| Terminated | 2019-04-03 |
| Distributed | Nationwide (US) |
| Quantity | 320 syringes |
| Reason classes | labeling, potency |
| NDC | 15082-0863-67 |
| Lot numbers | 0115, 0301, 0950, 1441, 15-86367S, 1505, 257-86367S, 387-86367S, 86367S |
| Expiration dates | 2017-06-09, 2017-06-16, 2017-06-19, 2017-06-23, 2017-06-25 |
Product
NitroGlycerin (1 mg/5 mL) 1 mg in 5% Dextrose Inj, USP QS 5 mL (200 mcg per mL), 5 mL Sterile single dose syringe, packaged in 8 x 5 (FORTY) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-863-67.
Reason for recall
Subpotent Drug: found to be below the specification for labeled assay.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0114-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.